A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts

Antibody validation

(2010) Jennifer Bordeaux et al.   BIOTECHNIQUES

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

(2010) József Tímár et al.   CLINICAL & EXPERIMENTAL METASTASIS

Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma

(2010) Stefanie Meyer et al.   EXPERIMENTAL DERMATOLOGY

Biomarkers: The Useful and the Not So Useful—An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma

(2010) Bonnie E. Gould Rothberg et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Consistency of random survival forests

(2010) Hemant Ishwaran et al.   STATISTICS & PROBABILITY LETTERS

Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms

(2009) Bonnie E. Gould Rothberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis

(2009) Bonnie E. Gould Rothberg et al.   JNCI-Journal of the National Cancer Institute

A multi-marker assay to distinguish malignant melanomas from benign nevi

(2009) M. Kashani-Sabet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy

(2008) Asfar S. Azmi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Melanoma Stem Cells: The Dark Seed of Melanoma

(2008) Susan E. Zabierowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant therapy of melanoma with interferon: lessons of the past decade

(2008) Paolo A Ascierto et al.   Journal of Translational Medicine